Institute for Experimental Cellular Therapy.
Institute for Transfusion Medicine, and.
Blood. 2016 Jul 7;128(1):120-9. doi: 10.1182/blood-2015-12-686238. Epub 2016 May 9.
The role of HLA amino acid (AA) polymorphism for the outcome of hematopoietic cell transplantation (HCT) is controversial, in particular for HLA class II. Here, we investigated this question in nonpermissive HLA-DPB1 T-cell epitope (TCE) mismatches reflected by numerical functional distance (FD) scores, assignable to all HLA-DPB1 alleles based on the combined impact of 12 polymorphic AAs. We calculated the difference in FD scores (ΔFD) of mismatched HLA-DPB1 alleles in patients and their 10/10 HLA-matched unrelated donors of 379 HCTs performed at our center for acute leukemia or myelodysplastic syndrome. Receiver-operator curve-based stratification into 2 ΔFD subgroups showed a significantly higher percentage of nonpermissive TCE mismatches for ΔFD >2.665, compared with ΔFD ≤2.665 (88% vs 25%, P < .0001). In multivariate analysis, ΔFD >2.665 was significantly associated with overall survival (hazard ratio [HR], 1.40; 95% confidence interval [CI], 1.05-1.87; P < .021) and event-free survival (HR, 1.39; 95% CI, 1.05-1.82; P < .021), compared with ΔFD ≤2.665. These associations were stronger than those observed for TCE mismatches. There was a marked but not statistically significant increase in the hazards of relapse and nonrelapse mortality in the high ΔFD subgroup, whereas no differences were observed for acute and chronic graft-versus-host disease. Seven nonconservative AA substitutions in peptide-binding positions had a significantly stronger impact on ΔFD compared with 5 others (P = .0025), demonstrating qualitative differences in the relative impact of AA polymorphism in HLA-DPB1. The novel concept of ΔFD sheds new light onto nonpermissive HLA-DPB1 mismatches in unrelated HCT.
HLA 氨基酸(AA)多态性对造血细胞移植(HCT)结果的作用存在争议,特别是对于 HLA Ⅱ类。在这里,我们根据 12 个多态性 AA 的综合影响,基于可分配给所有 HLA-DPB1 等位基因的数值功能距离(FD)分数,研究了非相容 HLA-DPB1 T 细胞表位(TCE)不匹配的问题。我们计算了中心进行的 379 例急性白血病或骨髓增生异常综合征患者及其 10/10 HLA 匹配的无关供体中不匹配 HLA-DPB1 等位基因的 FD 分数差异(ΔFD)。基于接收者操作特征曲线的分层,将 2 ΔFD 亚组分为ΔFD>2.665 和ΔFD≤2.665,结果显示前者非许可 TCE 不匹配的百分比显著更高,分别为 88%和 25%(P<.0001)。多变量分析显示,与 ΔFD≤2.665 相比,ΔFD>2.665 与总生存(危险比[HR],1.40;95%置信区间[CI],1.05-1.87;P<.021)和无事件生存(HR,1.39;95%CI,1.05-1.82;P<.021)显著相关。与 TCE 不匹配相比,这些关联更强。在高ΔFD 亚组中,复发和非复发死亡率的风险明显增加,但无统计学意义,而急性和慢性移植物抗宿主病则没有差异。在肽结合位置的 7 个非保守 AA 取代与另外 5 个相比具有更强的 FD 影响(P=.0025),这表明 HLA-DPB1 中 AA 多态性的相对影响存在定性差异。FD 差值的新概念为无关 HCT 中的非许可 HLA-DPB1 不匹配提供了新的视角。